Search Results

There are 2646 results for: content related to: A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical data

  1. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Article first published online : 8 JUN 2012, DOI: 10.1002/pds.3296

  2. Balancing benefit and risk of medicines: a systematic review and classification of available methodologies

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 7, July 2014, Pages: 667–678, Shahrul Mt-Isa, Christine E. Hallgreen, Nan Wang, Torbjörn Callréus, Georgy Genov, Ian Hirsch, Stephen F. Hobbiger, Kimberley S. Hockley, Davide Luciani, Lawrence D. Phillips, George Quartey, Sinan B. Sarac, Isabelle Stoeckert, Ioanna Tzoulaki, Alain Micaleff, Deborah Ashby and On behalf of the IMI-PROTECT benefit–risk participants

    Article first published online : 13 MAY 2014, DOI: 10.1002/pds.3636

  3. Disease risk score as a confounder summary method: systematic review and recommendations

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 2, February 2013, Pages: 122–129, Mina Tadrous, Joshua J. Gagne, Til Stürmer and Suzanne M. Cadarette

    Article first published online : 21 NOV 2012, DOI: 10.1002/pds.3377

  4. Terminal illness and the increased mortality risk of conventional antipsychotics in observational studies: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 2, February 2016, Pages: 113–122, Hendrika J. Luijendijk, Niels C. de Bruin, Tessa A. Hulshof and Xander Koolman

    Article first published online : 25 NOV 2015, DOI: 10.1002/pds.3912

  5. Is the Quebec provincial administrative database a valid source for research on chronic non-cancer pain?

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 9, September 2015, Pages: 980–990, Anaïs Lacasse, Mark A. Ware, Marc Dorais, Hélène Lanctôt and Manon Choinière

    Article first published online : 24 JUN 2015, DOI: 10.1002/pds.3820

  6. You have full text access to this OnlineOpen article
    Methodological gaps in the assessment of risk minimization interventions: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 6, June 2014, Pages: 572–579, Inna Gridchyna, Anne-Marie Cloutier, Lenhangmbong Nkeng, Camille Craig, Sarah Frise and Yola Moride

    Article first published online : 24 FEB 2014, DOI: 10.1002/pds.3596

  7. Community pharmacists' adoption of medicines reclassified from prescription-only status: a systematic review of factors associated with decision making

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 396–406, Vibhu Paudyal, Denise Hansford, Scott Cunningham and Derek Stewart

    Article first published online : 23 FEB 2012, DOI: 10.1002/pds.3219

  8. Case-crossover study design in pharmacoepidemiology: systematic review and recommendations

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 11, November 2013, Pages: 1146–1153, Giulia P. Consiglio, Andrea M. Burden, Malcolm Maclure, Lisa McCarthy and Suzanne M. Cadarette

    Article first published online : 13 SEP 2013, DOI: 10.1002/pds.3508

  9. Literature review of visual representation of the results of benefit–risk assessments of medicinal products

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 3, March 2016, Pages: 238–250, Christine E. Hallgreen, Shahrul Mt-Isa, Alfons Lieftucht, Lawrence D. Phillips, Diana Hughes, Susan Talbot, Alex Asiimwe, Gerald Downey, Georgy Genov, Richard Hermann, Rebecca Noel, Ruth Peters, Alain Micaleff, Ioanna Tzoulaki, Deborah Ashby and On behalf of PROTECT Benefit–Risk group

    Article first published online : 2 NOV 2015, DOI: 10.1002/pds.3880

  10. Adverse drug events in patients admitted to an emergency department: an analysis of direct costs

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 2, February 2015, Pages: 176–186, Florian Meier, Renke Maas, Anja Sonst, Andrius Patapovas, Fabian Müller, Bettina Plank-Kiegele, Barbara Pfistermeister, Oliver Schöffski, Thomas Bürkle and Harald Dormann

    Article first published online : 17 JUN 2014, DOI: 10.1002/pds.3663

  11. Design of a score to identify hospitalized patients at risk of drug-related problems

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 9, September 2014, Pages: 923–932, Olatz Urbina, Olivia Ferrández, Santiago Grau, Sonia Luque, Sergi Mojal, Monica Marin-Casino, Javier Mateu-de-Antonio, Alexia Carmona, David Conde-Estévez, Merce Espona, Elena González, Marta Riu and Esther Salas

    Article first published online : 10 MAY 2014, DOI: 10.1002/pds.3634

  12. Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 6, June 2013, Pages: 623–631, Adriana M. Hung, Christianne L. Roumie, Robert A. Greevy, Xulei Liu, Carlos G. Grijalva, Harvey J. Murff and Marie R. Griffin

    Article first published online : 17 APR 2013, DOI: 10.1002/pds.3432

  13. Variable selection on large case-crossover data: application to a registry-based study of prescription drugs and road traffic crashes

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 2, February 2014, Pages: 140–151, Marta Avalos, Ludivine Orriols, Hélène Pouyes, Yves Grandvalet, Frantz Thiessard, Emmanuel Lagarde and on behalf of the CESIR research group

    Article first published online : 18 OCT 2013, DOI: 10.1002/pds.3539

  14. Use of case–time–control design in pharmacovigilance applications: exploration with high-risk medications and unplanned hospital admissions in the Western Australian elderly

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 11, November 2013, Pages: 1159–1170, Sylvie D. Price, C. D'Arcy J. Holman, Frank M. Sanfilippo and Jon D. Emery

    Article first published online : 25 JUN 2013, DOI: 10.1002/pds.3469

  15. You have free access to this content
    Evaluating different physician's prescribing preference based instrumental variables in two primary care databases: a study of inhaled long-acting beta2-agonist use and the risk of myocardial infarction

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue S1, March 2016, Pages: 132–141, Md. Jamal Uddin, Rolf H. H. Groenwold, Anthonius de Boer, Ana S. M. Afonso, Paola Primatesta, Claudia Becker, Svetlana V. Belitser, Arno W. Hoes, Kit C. B. Roes and Olaf H. Klungel

    Article first published online : 1 APR 2016, DOI: 10.1002/pds.3860

  16. Electronic healthcare databases for active drug safety surveillance: is there enough leverage?

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 6, June 2012, Pages: 611–621, Preciosa M. Coloma, Gianluca Trifirò, Martijn J. Schuemie, Rosa Gini, Ron Herings, Julia Hippisley-Cox, Giampiero Mazzaglia, Gino Picelli, Giovanni Corrao, Lars Pedersen, Johan van der Lei, Miriam Sturkenboom and on behalf of the EU-ADR consortium

    Article first published online : 8 FEB 2012, DOI: 10.1002/pds.3197

  17. Patient population with multiple myeloma and transitions across different lines of therapy in the USA: an epidemiologic model

    Pharmacoepidemiology and Drug Safety

    Javier Cid Ruzafa, Evie Merinopoulou, Rebecca F. Baggaley, Pamela Leighton, Winifred Werther, Diana Felici and Andrew Cox

    Article first published online : 19 JAN 2016, DOI: 10.1002/pds.3927

  18. Exploring the possible association between montelukast and neuropsychiatric events among children with asthma: a matched nested case-control study

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 4, April 2015, Pages: 435–445, Mir M. Ali, Catherine E. O'Brien, Mario A. Cleves and Bradley C. Martin

    Article first published online : 12 FEB 2015, DOI: 10.1002/pds.3758

  19. Levofloxacin and proton pump inhibitor-based triple therapy versus standard triple first-line therapy for Helicobacter pylori eradication

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 5, May 2014, Pages: 443–455, Chen-Li Ye, Guo-Ping Liao, Shuai He, Yan-Na Pan, Ying-Bo Kang and Zhong-Yi Zhang

    Article first published online : 21 FEB 2014, DOI: 10.1002/pds.3581

  20. Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 6, June 2015, Pages: 619–627, Joshua A. Roth, Katharine Bradley, Kenneth E. Thummel, David L. Veenstra and Denise Boudreau

    Article first published online : 8 APR 2015, DOI: 10.1002/pds.3769